OPTIMIZATION OF ISOLATION, LOW-SERUM CULTURING, AND IMMUNOPHENOTYPING OF HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLS
Experemental medicine

OPTIMIZATION OF ISOLATION, LOW-SERUM CULTURING, AND IMMUNOPHENOTYPING OF HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLS

Published 2026-09-30

Authors:

Dovgalyuk A.I.
I.Horbachevsky Ternopil National Medical University image/svg+xml
https://orcid.org/0000-0003-3976-0245
Redko O.S.
I.Horbachevsky Ternopil National Medical University image/svg+xml
https://orcid.org/0000-0002-9860-9003
Petrenko N.V.
I.Horbachevsky Ternopil National Medical University image/svg+xml
https://orcid.org/0000-0003-1780-6951
Lavrenchuk H.Y.
State Institution "National Research Center for Radiation Medicine of National Academy of Medical Sciences of Ukraine"
https://orcid.org/0000-0001-7200-712X
Kyryk V.M.
State Institution “National Scientific Center “The M.D. Strazhesko Institute of Cardiology, Clinical and Regenerative Medicine of the National Academy of Medical Sciences of Ukraine”
https://orcid.org/0000-0001-7636-1302
Korda M.M.
I.Horbachevsky Ternopil National Medical University image/svg+xml
https://orcid.org/0000-0003-0676-336X

Abstract:
Mesenchymal stem cells from the human umbilical cord are a promising resource for cell therapy due to low immunogenicity and non-invasive harvesting. This study optimized an isolation protocol using collagenase I and evaluated cell properties during expansion. Umbilical cord explants were digested with 0.1 % collagenase I and cultured in Advanced DMEM/F12 with 2–10 % fetal bovine serum for 10 passages. Immunophenotypic analysis was performed via flow cytometry. Primary cells exhibited typical adherent fibroblast-like morphology. Low-serum maintenance (2 % fetal bovine serum) supported robust expansion without spontaneous differentiation. Flow cytometry confirmed high expression of positive markers (CD73, CD90, CD105) and complete absence of negative markers (CD34, CD45, HLA-DR). This protocol allows efficient isolation and expansion of human umbilical cord mesenchymal stem cells while maintaining their canonical immunophenotype under low-serum conditions, minimizing foreign protein exposure for future clinical applications.
Keywords:
mesenchymal stem cells umbilical cord cell culture immunophenotyping low-serum media flow cytometry
References:
  1. Al Barashdi MA, Ali A, McMullin MF, Mills K. Protein tyrosine phosphatase receptor type C (PTPRC or CD45). Journal of Clinical Pathology. 2021;74(9):548-552. doi: 10.1136/jclinpath-2020-206927
  2. Abouelnaga H, El-Khateeb D, Moemen Y, El-Fert A, Elgazzar M, Khalil A. Characterization of mesenchymal stem cells isolated from Wharton's jelly of the human umbilical cord. Egyptian Liver Journal. 2022;12:1-9. doi: 10.1186/s43066-022-00216-x
  3. Cai C, Li H, Tian Z, Liang Q, Shen R, Wu Z, et al. HGF secreted by hUC-MSCs mitigates neuronal apoptosis to repair the injured spinal cord via phosphorylation of Akt/FoxO3a pathway. Biochemical and Biophysical Research Communications. 2024;692:149321. doi: 10.1016/j.bbrc.2023.149321
  4. Castro Ramos A, Widjaja Lomanto MY, Vuong CK, Ohneda O, Fukushige M. Antibacterial effects of human mesenchymal stem cells and their derivatives: A systematic review. Frontiers in Microbiology. 2024;15:1430650. doi: 10.3389/fmicb.2024.1430650
  5. Celikkan FT, Mungan C, Sucu M, Ulus AT, Cinar O, Ili EG, et al. Optimizing the transport and storage conditions of current Good Manufacturing Practice grade human umbilical cord mesenchymal stromal cells for transplantation. Cytotherapy. 2019;21(1):64-75. doi: 10.1016/j.jcyt.2018.10.007
  6. Choudhery MS. Perinatal tissue-derived stem cells: An emerging source for regenerative medicine. Cells. 2021;10(12):3278. doi: 10.3390/cells10123278
  7. De Francesco F, Sagnella N, Riccio V, Riccio M. Procurement, Processing, and Storage of Human Amniotic Membrane: A Comprehensive Review. Diagnostics. 2025;15(3):144-159. doi: 10.3390/diagnostics15030144
  8. Dovgalyuk A, Levkiv M, Dudkevych O, Pokryshko O. Antimicrobial properties of mesenchymal stem cells: prospects for application against antibiotic-resistant infections. Cell Organ Transpl. 2025; 13(2):e2025132185. doi: 10.22494/cot.v13-2.185
  9. Fu Q, Han M, Dai X, Lu R, Deng E, Shen X, et al. Therapeutic effect of three-dimensional hanging drop cultured human umbilical cord mesenchymal stem cells on osteoarthritis in rabbits. Stem Cell Research & Therapy. 2024;15(1):311. doi: 10.1186/s13287-024-03905-y
  10. Galgaro BC, Beckenkamp LR, Nunnenkamp M, Korb VG, Naasani LI, Roszek K, et al. The adenosinergic pathway in mesenchymal stem cell fate and functions. Medicinal Research Reviews. 2021;41(4):2316-2349. doi: 10.1002/med.21796
  11. He J, Yao X, Mo P, Wang K, Yang ZL, Tian NN, et al. Lack of tumorigenesis and protumorigenic activity of human umbilical cord mesenchymal stem cells in NOD SCID mice. BMC Cancer. 2022;22(1):307. doi: 10.1186/s12885-022-09431-5
  12. Kang M, Yang Y, Zhang H, Zhang Y, Wu Y, Denslin V, et al. Comparative Analysis of Serum and Serum-Free Medium Cultured Mesenchymal Stromal Cells for Cartilage Repair. International Journal of Molecular Sciences. 2024;25(19):10627. doi: 10.3390/ijms251910627
  13. Pilgrim CR, McCahill KA, Rops JG, Dufour JM, Russell KA, Koch TG. A review of fetal bovine serum in the culture of mesenchymal stromal cells and potential alternatives for veterinary medicine. Frontiers in Veterinary Science. 2022;9:859025. doi: 10.3389/fvets.2022.859025
  14. Radu P, Zurzu M, Paic V, Bratucu M, Garofil D, Tigora A, et al. CD34 Structure, functions and relationship with cancer stem cells. Medicina. 2023;59(5):938. doi: 10.3390/medicina59050938
  15. Redko O, Dovgalyuk A, Kramar S, Ohinska N, Nebesna Z, Korda M. Mesenchymal stem cell therapy modulates macrophage dynamics in ARDS-associated liver injury in rats. Cell Organ Transpl. 2023; 11(2):114-121. Available from: https://doi.org/10.22494/cot.v11i2.157
  16. Renesme L, Pierro M, Cobey KD, Mital R, Nangle K, Shorr R, et al. Definition and characteristics of mesenchymal stromal cells in preclinical and clinical studies: a scoping review. Stem Cells Translational Medicine. 2022;11(1):44-54. doi: 10.1093/stcltm/szab011
  17. Rossi E, Bernabeu C. Novel vascular roles of human endoglin in pathophysiology. Journal of Thrombosis and Haemostasis. 2023;21(9):2327-2338. doi: 10.1016/j.jth.2023.05.023
  18. Saalbach A, Anderegg U. Thy-1: more than a marker for mesenchymal stromal cells. The FASEB Journal. 2019;33(6):6689-6696. doi: 10.1096/fj.201802134R
  19. Todtenhaupt P, Franken LA, Groene SG, van Hoolwerff M, van der Meeren LE, van Klink JM, et al. A robust and standardized method to isolate and expand mesenchymal stromal cells from human umbilical cord. Cytotherapy. 2023;25(10):1057-1068. doi: 10.1016/j.jcyt.2023.06.004
  20. Trigo CM, Rodrigues JS, Camões SP, Solà S, Miranda JP. Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? Journal of Advanced Research. 2024;65:120-135. doi: 10.1016/j.jare.2023.12.019
  21. Xie Q, Liu R, Jiang J, Peng J, Yang C, Zhang W, et al. What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment? Stem Cell Research & Therapy. 2020;11:1-13. doi: 10.1186/s13287-020-02011-x
  22. Zhao Q, Zhang L, Wei Y, Yu H, Zou L, Huo J, et al. Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease. Stem Cell Research & Therapy. 2019;10:1-14. doi: 10.1186/s13287-019-1478-4
Publication:
«World of Medicine and Biology» Vol. 22 No. 97 (2026), pp. 185-189
UDC 611.013.395:611.013.8